NEWSBLARE’s Post

The ripple effects of this withdrawal could be significant. Healthcare sectors will face immediate impacts, including shifts in vaccine supply chains and potential increases in cost as providers and governments transition to alternative vaccines. This will also influence investment in pharmaceutical R&D, potentially slowing down the innovation of new treatments. Moreover, the economic implications extend beyond healthcare. For eg, insurance industries might need to adjust their risk assessments and policies regarding vaccine coverage and compensation. There could also be impacts on global travel, especially if vaccine requirements shift, affecting tourism and business travel sectors. Overall, while the direct health implications are paramount, the indirect effects on global economic stability and sectoral operations will also merit close observation as the situation unfolds. #HealthcareIndustry #EconomicImpact #VaccineConfidence

Non-COVID-19 Vaccines Get Post-Pandemic Boost, reports Kalorama Information Increases were notable in several vaccine areas, including: - #Shingles - #HPV - #Meningitis - #Rotavirus - #RSV Read more in the latest blog by Kalorama Information - https://lnkd.in/gjErcmgu #Vaccine #Vaccines #Covid19 #marketresearch #mrx #healthcare #Pharmaceuticals #pandemic

Pfizer vs Sanofi The following dispute is not about a coronavirus #vaccine, but about Pfizer's pneumococcal vaccine 💉 and the associated #intellectual #property rights. Sanofi filed a #lawsuit against this in the USA because it was obvious and therefore not new. This has now been confirmed by the application of the result-effective variable doctrine in the obviousness analysis, so that the #patent was and remains declared invalid. (https://lnkd.in/ecaMFf89) Further #proceedings will follow to determine whether the court has correctly applied the burden of proof. These proceedings are still pending. However, it is clear to see that #competition for patents on vaccines is fiercely contested internationally. It remains exciting to see how this dispute between the pharmaceutical companies will develop. Stay curious 😉

UK-based pharmaceutical giant AstraZeneca is withdrawing its COVID-19 vaccine globally, days after acknowledging in court documents that it can cause a rare and dangerous side effect. The company had earlier accepted a connection between the vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS), a condition marked by unusually low levels of platelets combined with blood clot formation. However, calling the decision "purely coincidental," the pharma giant stated that the vaccine is being withdrawn due to a "surplus of available updated vaccines" since the pandemic. "As multiple variant COVID-19 vaccines have since been developed, there is a surplus of available updated vaccines," the company said. AstraZeneca said that the surplus had led to a decline in demand for its vaccine, known as Vaxzevria since 2021, which is no longer being manufactured or supplied. According to a Telegraph report, The vaccine can no longer be used in the European Union after the company voluntarily withdrew its “marketing authorisation”. The report said the application to withdraw the vaccine was made on March 5 and came into effect on May 07, 2024. Similar withdrawal applications will be submitted in the UK and other countries. #vaccine #pharmaceuticals #pharma #india #covid19 #company #Indianstartupnews

The rapid development of Covid-19 vaccines was a testament to scientific innovation, but getting those #vaccines into the arms of billions around the world required overcoming significant logistical hurdles. We delve into lessons learnt from Covid-19 🤔 👇 https://lnkd.in/dfMGqzex #covid19 #vaccines #pharma #pharmalogistics #logisticsafrica

Meningococcal Vaccines Market is projected to grow at a CAGR of 6.32% by 2033 #Vaccines #TherapeuticDrugs > Download this new #Pharma report here > https://ow.ly/boq050Qmi2t

Flu vaccines and Covid 19 vaccines can be administered at the same time. This is known as coadministration. 💉 Always be sure to consult your pharmacist for any questions or concerns you may have. #pharma #vaccine #pharmacy #fluvaccine #flu #canada #ocp #ontariopharmacy #pharmaceutics #pharmaceutical #covid #covid19 #covid19vacccine💉 #vaccines #ᴠaccinessavelives #seasonal #cold #sick #buyinggroup #independentpharmacy #independentpharmacyowner #independentpharmacies

The recent announcement by AstraZeneca, a pharmaceutical company based in the UK, to globally withdraw its COVID-19 vaccine due to reported side effects, has led to the Serum Institute of India revealing that it ceased production of Covishield in December 2021. The decision was made in response to a decrease in demand for the vaccine and the emergence of new variants. A spokesperson for the Serum Institute of India stated that with India achieving high vaccination rates in 2021 and 2022, along with the appearance of new mutant strains, the need for previous vaccines has significantly decreased. As a result, production and distribution of additional doses of Covishield have been halted since December 2021. Read more: https://lnkd.in/e6Ds2peJ Renuka Abraham Swarna Jain Himanshu Chandel Felina Das Swapna Singh Arnav Bose Priyal Jain Likhita Agrawal Manisha Arora Rahul Parekh Vinita Jagtiani Tanvi Shetty #healthcare #covid #Covishield #India #lifesciences #pharma

Join Unimarck Pharma in commemorating National Vaccination Day as we continue our commitment to public health and safeguarding communities through our wide range of pharmaceutical products. Together, let's strengthen immunity and build a healthier tomorrow. 🌟 . . . #unimarckpharma #nationalvaccinationday #vaccineswork #immunizationwork #publichealth #pharmaceuticalindustry #pharmacompany #pharmaindustry #pharmaceuticals #pharma #medicine #pharmacompanies #manufacturers #thirdpartyservices #thirdpartymanufacturing #thirdpartymanufacturers #contractmanufacturer #manufacturing

Mainstream news reporting. Pfizer Says They’re ‘Deeply Sorry’ For Violating 5 Regulatory Codes And Illegally Promoting Their Vaccine. "According to the Prescription Medicines Code of Practice Authority, Pfizer promoted unlicensed medicines and violated a total of five regulatory codes. The pharmaceutical giant has been accused of "bringing discredit" to the industry after employees promoted the COVID-19 vaccine across social media during the height of the pandemic. Per Biopharma-reporter, medical director of Pfizer Dr. Berkley Phillips retweeted a post on Twitter, now known as X, stating: "Our vaccine candidate is 95% effective in preventing COVID and 94% effective in people over 65 years old. Bio-Pharma obtained a statement from a spokesman of Pfizer, claiming the company is "deeply sorry" and "fully recognizes and accepts" the issues highlighted by the PMCPA ruling. On the other hand, Pfizer claimed it took its commitment to the code extremely seriously and had conducted a thorough investigation. Per the website, the case was received February 2023 and was marked completed as of March 1. See more on the full report regarding Complaint V. Pfizer https://lnkd.in/dYBaxTMa Wow.. what do you think? LIKE, SHARE AND COMMENT Stay in touch by SUBSCRIBING to our mailing list via our website link below; website: https://lnkd.in/dvH8hj4F Youtube: https://lnkd.in/dfTmTnVG Rumble: https://lnkd.in/djbyTQSy Source